Adverse events associated with supplements containing ephedra alkaloids.
作者信息
Geiger Jonathan D
机构信息
University of Manitoba, Winnipeg, Manitoba, Canada.
出版信息
Clin J Sport Med. 2002 Jul;12(4):263. doi: 10.1097/00042752-200207000-00014.
Abstract
摘要
相似文献
1
Adverse events associated with supplements containing ephedra alkaloids.
Clin J Sport Med. 2002 Jul;12(4):263. doi: 10.1097/00042752-200207000-00014.
2
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
N Engl J Med. 2000 Dec 21;343(25):1833-8. doi: 10.1056/NEJM200012213432502.
3
Ergogenic aids: an update on ephedra.
Curr Sports Med Rep. 2005 Aug;4(4):231-5. doi: 10.1007/s11932-005-0042-4.
4
Ephedra banned.
AWHONN Lifelines. 2004 Feb-Mar;8(1):19-25. doi: 10.1111/j.1552-6356.2004.tb00151.x.
5
Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
Am J Psychiatry. 2005 Jan;162(1):189-91. doi: 10.1176/appi.ajp.162.1.189.
6
HHS to study ephedra, step up enforcement against illegal marketing.
FDA Consum. 2002 Sep-Oct;36(5):3.
7
Ephedra ban: no shortage of reasons.
FDA Consum. 2004 Mar-Apr;38(2):6-7.
8
Cardiovascular effects of ephedra alkaloids: a comprehensive review.
Prog Cardiovasc Dis. 2005 Jan-Feb;47(4):217-25. doi: 10.1016/j.pcad.2004.07.006.
9
The need for regulation of dietary supplements--lessons from ephedra.
JAMA. 2003 Mar 26;289(12):1568-70. doi: 10.1001/jama.289.12.1568. Epub 2003 Mar 10.
10
Working to get ephedra banned.
Consum Rep. 2003 Feb;68(2):6.
引用本文的文献
1
Modelling the cardiovascular effects of ephedrine.
Br J Clin Pharmacol. 2004 May;57(5):552-62. doi: 10.1111/j.1365-2125.2003.02062.x.
Zotero 插件